The monthslong battle over the future of the weight-loss drug industry is headed for a climax this week, when the Food and ...

Mike Plante struggled with his weight for years, but within six months of starting with the injection drug semaglutide, a ...

Health-care companies fell amid concerns about regulation from the Trump administration. A retreat for UnitedHealth Group continued after President-elect Donald Trump vowed to root "middle men" out of ...

Investors' focus could, however, shift back onto the possible market impacts of GLP-1 agonists in 2025, particularly as a result of a major expansion of current supplies after Novo Nordisk was given a ...

Part of the joy of the season may be gone — or feel different — for people who are taking popular weight-loss drugs and can't ...

The president-elect is set to appear with SoftBank Group CEO Masayoshi Son at Mar-a-Lago on Monday. The industrial conglomerate said its board continued to explore strategic alternatives and plans to ...

Pharmaceutical and biotech stocks often are seen as steady and safe options for investors for one particular reason. Patients ...